JMED - Jones Pharma (specialty pharmaceutical mfr) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : JMED - Jones Pharma (specialty pharmaceutical mfr)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: babette spatz who wrote (215)	5/13/1999 11:47:00 AM
From: wbASSETt	Read Replies (1) of 268

Babette, I got it the first time. I still think that this info IS positive since this is the first year where Jones made earning increase, without the additional acquisitions. It shows that the previous buy-outs are matriculated into jones and are improving on their previous year. The fact that Jones doesn't doll out earnings in the form of large dividends is fine with me as long as he does either of 3 things 1) uses the $ to generate >15% earnings growth 2) uses $ to invest into research 3) uses the $ for buy-outs to increase capacity and earnings. I believe that Jones will announce a buy out candidate before the end of the year (based on the company rhetoric of recent times) IMHO wbASSETt

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next